Falgun Shah

Falgun Shah

Central US Merck & Co., Inc. - Kenilworth / United States
Others
AD Scientific Index ID: 4395423
-
person_outline Falgun Shah's MOST POPULAR ARTICLES
1-) Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro AssaysF Shah, L Leung, HA Barton, Y Will, AD Rodrigues, N Greene, MD AleoToxicological Sciences 147 (2), 500-514, 2015992015
2-) Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor libraryF Shah, P Mukherjee, J Gut, J Legac, PJ Rosenthal, BL Tekwani, ...Journal of chemical information and modeling 51 (4), 852-864, 2011812011
3-) Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapyP Mukherjee, A Pradhan, F Shah, BL Tekwani, MA AveryBioorganic & medicinal chemistry 16 (9), 5254-5265, 2008692008
4-) Inhibitors of SARS-3CLpro: Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation StudiesP Mukherjee, F Shah, P Desai, M AveryJournal of chemical information and modeling 51 (6), 1376-1392, 2011562011
5-) Moving beyond binary predictions of human drug-induced liver injury (DILI) toward contrasting relative risk potentialMD Aleo, F Shah, S Allen, HA Barton, C Costales, S Lazzaro, L Leung, ...Chemical research in toxicology 33 (1), 223-238, 2019532019